AbbVie Inc
ABBV
$283.37+0.57%
End of day · as of Oct 15, 2026, 5:17 PM ET
Mkt cap
$334.34B
EV/Sales
N/A
P/E ratio
80.0
Revenue (qtr ended 2026-06-30)
$16.99B
EPS (TTM)
$3.54
Gross Margin (qtr ended 2026-06-30)
74.74%
Profit Margin (qtr ended 2026-06-30)
21.27%
Beta
0.49
Div yield
3.53%
Sector
Healthcare
AbbVie Inc (ABBV) is a drug manufacturers - general company listed on US. It is led by Rob Michael.
Latest reported ABBV revenue for 2026-06-30 was $16.99B. Net income was $3.61B. Revenue was up 13.3% from 2026-03-31 to 2026-06-30. ABBV currently screens at market cap $334.34B and trailing P/E 80.0.
Use this ABBV research hub for sector, financials, and filings — not a live tape.
Each line names its own latest cached period. Full ABBV income, balance, and cash tables.
AbbVie Inc (ABBV) is a drug manufacturers - general company in the Healthcare sector.
Latest cached AbbVie Inc (ABBV) revenue for Jun 30, 2026 was $16.99B. Net income was $3.61B. Statements: https://lician.com/financials/abbv
AbbVie Inc (ABBV) trailing P/E is 80.0 on the latest cached fundamentals snapshot.
AbbVie Inc (ABBV) market capitalization is $334.34B on the latest cached snapshot.
AbbVie Inc (ABBV) cached previous close $281.75; day range $283.37 – $288.28; volume 6,730,071. Session quote: https://lician.com/quote/abbv
AbbVie Inc (ABBV) latest cached earnings event is "ABBV earnings" on Oct 30, 2026. Earnings calendar: https://lician.com/earnings
The latest cached ABBV filing is 8-K · Oct 15, 2026. Filings: https://lician.com/sec/abbv